文献速递颈动脉与弓上血管

无症状颈动脉狭窄最佳药物治疗下五年脑缺血事件的前瞻性研究

Cerebral Ischaemic Events in Asymptomatic Carotid Stenosis under Best Medical Therapy: Five Year Results of a Prospective Study (Carotid Asymptomatic Stenosis Study).
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-03-02

CARAS 研究前瞻性观察 307 例不适合血运重建的无症状颈动脉狭窄≥60% 患者,接受最佳药物治疗并随访五年,累计脑缺血事件率为 6±2%,年发生率 1.3%,斑块进展和对侧狭窄≥60% 独立增加事件风险。

要点

  • 无症状颈动脉狭窄≥60% 接受最佳药物治疗者五年累计脑缺血事件率 6±2%。
  • 斑块进展与对侧狭窄≥60% 独立增加同侧脑缺血事件风险。
  • 最佳药物治疗下事件风险较低,或可优化血运重建指征。

核心结论

  • 无症状颈动脉狭窄患者接受最佳药物治疗的脑缺血事件风险相对较低。
  • 斑块进展和对侧颈动脉狭窄≥60% 会增加脑缺血事件风险。
  • 这些发现可能有助于细化颈动脉血运重建的指征。

研究设计与样本

  • 前瞻性观察性队列研究(CARAS,NCT04825080),2019 至 2020 年入组,计划五年随访。
  • 纳入无症状颈动脉狭窄≥60%(NASCET 标准)且因手术高风险或无斑块易损性不适合血运重建的患者。
  • 共纳入 307 例患者,平均年龄 80±7 岁,54.4% 为男性。
  • 最佳药物治疗定义为恰当使用抗血小板药、他汀、降压药和戒烟。
  • 随访包括每年临床和超声评估及每六个月电话访谈。

主要发现

  • 随访期间发生 8 例(2.6%)同侧卒中和 14 例(4.6%)短暂性脑缺血发作,共 20 例脑缺血事件。
  • 五年生存率为 80±2%,累计脑缺血事件率为 6±2%,年发生率为 1.3%。
  • 双侧颈动脉狭窄≥60% 者脑缺血事件率更高(9.3±4% vs. 3.4±1%;p=.001)。
  • 多变量 Cox 分析显示斑块进展(HR 3.2,95%CI 1.1-9.2)和对侧狭窄≥60%(HR 3.6,95%CI 1.2-10.5)独立关联脑缺血事件高风险。

临床怎么用

  • 对无症状颈动脉狭窄≥60% 且不适合血运重建者,最佳药物治疗下脑缺血事件风险较低。
  • 随访中应关注斑块进展和对侧狭窄≥60%,这些患者脑缺血事件风险较高。
  • 斑块进展和对侧狭窄≥60% 可作为细化血运重建指征的参考因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The role of carotid revascularisation in asymptomatic carotid artery stenosis (ACAS) remains debated. Advances in best medical therapy (BMT) may have lowered the risk of cerebral ischaemic events (CIEs), but optimal treatment strategies are still unclear. This study presents the five year results from a prospective, observational cohort of ACAS patients treated with BMT in a real world setting. METHODS: The Carotid Asymptomatic Stenosis Study (CARAS) study (NCT04825080) enrolled patients with ACAS ≥60% (North American Symptomatic Carotid Endarterectomy Trial [NASCET] criteria) who were ineligible for revascularisation due to high surgical risk or absence of plaque vulnerability, between 2019 and 2020, with planned five year follow up. BMT was defined as appropriate use of antiplatelets, statins, antihypertensives, and smoking cessation. The primary endpoint was the rate of ipsilateral CIE (stroke, transient ischaemic attack [TIA], or amaurosis fugax). Secondary endpoints were plaque progression, identification of predictors of CIE, BMT adherence, and survival. Follow up included annual clinical and duplex scan assessments and six month telephone interviews. RESULTS: The study enrolled 307 patients with a mean age of 80 ± 7 years; 54.4% were men. Bilateral carotid artery stenosis ≥60% was present in 61 (19.9%) patients. At enrolment, 238 (77.5%) patients were on BMT. During follow up, there were eight (2.6%) ipsilateral strokes and 14 (4.6%) TIAs, for a total of 20 CIEs (two patients had TIA and stroke). The five year survival was 80 ± 2%, and the cumulative CIE rate was 6 ± 2% and CIE annual rate was 1.3%. Sixty five (21.2%) patients had carotid stenosis progression, which was associated with a higher risk of CIE compared with patients with stable plaques (9.2 ± 4% vs. 4.5 ± 1%; p = .010). Similarly, bilateral carotid artery stenosis ≥60% was associated with a higher CIE rate (9.3 ± 4% vs. 3.4 ± 1%; p = .001). These two factors were independently associated with high risk of CIE in the multivariable Cox analysis (hazard ratio [HR] 3.2, 95% confidence interval [CI] 1.1 - 9.2; and HR 3.6, 95% CI 1.2 - 10.5). CONCLUSION: ACAS patients under BMT have a relatively low CIE risk, but plaque progression and contralateral stenosis increase it. These findings may help refine indications for carotid revascularisation.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Pini R, Rocchi C, Lodato M, et al. Cerebral Ischaemic Events in Asymptomatic Carotid Stenosis under Best Medical Therapy: Five Year Results of a Prospective Study (Carotid Asymptomatic Stenosis Study). Eur J Vasc Endovasc Surg. 2026. PMID: 41780713. doi:10.1016/j.ejvs.2026.02.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。